Luis Meza
0000-0002-0235-297X
27 papers found
Refreshing results…
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma
Biomarker approach harnessed in trials of personalized medicine for bladder cancer
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
Is there a role for novel TKI/ICI combinations in metastatic renal cell carcinoma? Definitely maybe
Immune Related Adverse Events
Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? Yes, cytoreductive nephrectomy should still be considered
Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
Missing publications? Search for publications with a matching author name.